Over 30 network leaders of PLHIV from 18 are congregating in Nairobi to brainstorm a new strategy to HIV response .

In the early 1980s, the virus’s ravages were treated as “something that happens over there, only to those people,” Juan ...

Despite the silence that stigma often brings, the joy and power of Black people living with HIV are loud when you know where ...

A modelling study shows the six-monthly anti-HIV jab, lenacapavir, could end Aids in SA by 2032 — but only if between two and four million HIV-negative people in the country would need to use the jab ...

Africa bears a disproportionate infectious disease burden, with HIV, tuberculosis, and malaria posing ongoing threats ...

Lenacapavir, a once-a-year injection, can treat HIV, prevent transmission and stop new infections — all with a single shot.

Some hospitals have reduced refill stock given to patients, for example, some give medicine to last for only 30 days, a drop ...

Professor Thumbi Ndung'u and his team at the Africa Health Research Institute are pioneering a study that explores innovative ...

The low-cost test developed by Professor Vinayak Dravid and research professor Gajendra Shekhawat builds on an existing ...

Renuka warned of a potential surge in HIV cases among drug users, citing the vulnerability of this group to contract and spread the AIDS virus. Dr. Renuka’s concerns come after it was found that ...

ART also cuts the number of new infections by suppressing the virus in people living with HIV, thus preventing transmission, he told Live Science in an email. "In the worst-case scenario ...

A ground-breaking HIV cure trial conducted in Durban has shown promising results in achieving antiretroviral therapy (ART)-free virus control. The trial revealed that 20% of participants remained ...